{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:38:22Z","timestamp":1784975902687,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Project to Attract High Level Foreign Experts","award":["G20200019016"],"award-info":[{"award-number":["G20200019016"]}]},{"name":"China Postdoctoral Scientific Foundation","award":["2020M683114"],"award-info":[{"award-number":["2020M683114"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The emergence of nonresponse or resistance to traditional chemotherapeutic agents is one of the main challenges of colorectal cancer (CRC) therapies. Thus, novel therapeutic drugs that can improve the clinical outcomes of CRC patients are urgently needed. The purpose of this study was to investigate the effects and mechanisms of pyrimethamine in CRC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and results<\/jats:title>\n                <jats:p>In this study, we assessed the role of pyrimethamine on CRC cell growth by cell counting kit-8 and colony formation assays. Cell cycle distribution and cellular senescence were determined by flow cytometry and senescence-associated \u03b2-galactosidase staining respectively. RNA-seq analysis and western blotting were used to investigate the potential pathways of pyrimethamine in CRC development. Moreover, animal experiments were performed to evaluate the effect of pyrimethamine in vivo. Our results demonstrated that pyrimethamine could inhibit cell growth by inducing S phase arrest followed by cellular senescence in CRC cells, and the p38MAPK-p53 axis was probably involved in that effect. In addition, pyrimethamine could also boost CD8<jats:sup>+<\/jats:sup> T-cell mediated cytotoxicity and exert antitumor activity in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results indicated that pyrimethamine may be a promising candidate agent for CRC treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11033-022-07262-y","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:03:02Z","timestamp":1646823782000},"page":"4281-4292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pyrimethamine inhibits cell growth by inducing cell senescence and boosting CD8+ T-cell mediated cytotoxicity in colorectal cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Haiyan","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangyu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5881-4299","authenticated-orcid":false,"given":"Xiangling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"issue":"1","key":"7262_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics. CA Cancer J Clin 71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"issue":"34","key":"7262_CR2","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.3748\/wjg.v24.i34.3834","volume":"24","author":"K Van der Jeught","year":"2018","unstructured":"Van der Jeught K, Xu HC, Li YJ, Lu XB, Ji G (2018) Drug resistance and new therapies in colorectal cancer. World J Gastroenterol 24(34):3834\u20133848. https:\/\/doi.org\/10.3748\/wjg.v24.i34.3834","journal-title":"World J Gastroenterol"},{"issue":"3","key":"7262_CR3","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1021\/acs.jmedchem.8b01754","volume":"62","author":"AT Hopper","year":"2014","unstructured":"Hopper AT, Brockman A, Wise A, Gould J, Barks J, Radke JB, Sibley LD, Zou Y, Thomas S (2014) Discovery of selective Toxoplasma gondii dihydrofolate reductase inhibitors for the treatment of toxoplasmosis. J Med Chem 62(3):1562\u20131576. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01754","journal-title":"J Med Chem"},{"issue":"9918","key":"7262_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s0140-6736(13)60024-0","volume":"383","author":"NJ White","year":"2014","unstructured":"White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM (2014) Malaria. The Lancet 383(9918):723\u2013735. https:\/\/doi.org\/10.1016\/s0140-6736(13)60024-0","journal-title":"The Lancet"},{"issue":"1","key":"7262_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00262-017-2057-0","volume":"67","author":"MW Khan","year":"2018","unstructured":"Khan MW, Saadalla A, Ewida AH, Al-Katranji K, Al-Saoudi G, Giaccone ZT, Gounari F, Zhang M, Frank DA, Khazaie K (2018) The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer. Cancer Immunol Immunother 67(1):13\u201323. https:\/\/doi.org\/10.1007\/s00262-017-2057-0","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"7262_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/CAD.0000000000000740","volume":"30","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zhou H, Yi T, Wang H (2019) Pyrimethamine exerts significant antitumor effects on human ovarian cancer cells both in vitro and in vivo. Anticancer Drugs 30(6):571\u2013578. https:\/\/doi.org\/10.1097\/CAD.0000000000000740","journal-title":"Anticancer Drugs"},{"issue":"3","key":"7262_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1158\/1535-7163.MCT-18-0936","volume":"18","author":"H Liu","year":"2019","unstructured":"Liu H, Qin Y, Zhai D, Zhang Q, Gu J, Tang Y, Yang J, Li K, Yang L, Chen S, Zhong W, Meng J, Liu Y, Sun T, Yang C (2019) Antimalarial drug pyrimethamine plays a dual role in antitumor proliferation and metastasis through targeting DHFR and TP. Mol Cancer Ther 18(3):541\u2013555. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-0936","journal-title":"Mol Cancer Ther"},{"key":"7262_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fphar.2020.00758","volume":"11","author":"X Zhou","year":"2020","unstructured":"Zhou X, Zhang J, Hu X, He P, Guo J, Li J, Lan T, Liu J, Peng L, Li H (2020) Pyrimethamine elicits antitumor effects on prostate cancer by inhibiting the p38-NF-kappaB pathway. Front Pharmacol 11:758. https:\/\/doi.org\/10.3389\/fphar.2020.00758","journal-title":"Front Pharmacol"},{"issue":"15","key":"7262_CR9","doi-asserted-by":"publisher","first-page":"8147","DOI":"10.3390\/ijms22158147","volume":"22","author":"YY Jung","year":"2021","unstructured":"Jung YY, Kim C, Ha IJ, Lee SG, Lee J, Um JY, Ahn KS (2021) Pyrimethamine modulates interplay between apoptosis and autophagy in chronic myelogenous leukemia cells. Int J Mol Sci 22(15):8147. https:\/\/doi.org\/10.3390\/ijms22158147","journal-title":"Int J Mol Sci"},{"issue":"4","key":"7262_CR10","doi-asserted-by":"publisher","first-page":"E95","DOI":"10.1002\/ajh.26084","volume":"96","author":"JR Brown","year":"2021","unstructured":"Brown JR, Walker SR, Heppler LN, Tyekucheva S, Nelson EA, Klitgaard J, Nicolais M, Kroll Y, Xiang M, Yeh JE, Chaudhury M, Giaccone ZT, Fernandes SM, Jacobsen ED, Fisher DC, Freedman AS, Davids MS, Supko JG, Wu C, Frank DA (2021) Targeting constitutively active STAT3 in chronic lymphocytic leukemia: a clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses. Am J Hematol 96(4):E95\u2013E98. https:\/\/doi.org\/10.1002\/ajh.26084","journal-title":"Am J Hematol"},{"issue":"1","key":"7262_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/15548627.2016.1247143","volume":"13","author":"H Tai","year":"2017","unstructured":"Tai H, Wang Z, Gong H, Han X, Zhou J, Wang X, Wei X, Ding Y, Huang N, Qin J, Zhang J, Wang S, Gao F, Chrzanowska-Lightowlers ZM, Xiang R, Xiao H (2017) Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence. Autophagy 13(1):99\u2013113. https:\/\/doi.org\/10.1080\/15548627.2016.1247143","journal-title":"Autophagy"},{"issue":"23\u201324","key":"7262_CR12","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1101\/gad.343129","volume":"34","author":"J Birch","year":"2020","unstructured":"Birch J, Gil J (2020) Senescence and the SASP: many therapeutic avenues. Genes Dev 34(23\u201324):1565\u20131576. https:\/\/doi.org\/10.1101\/gad.343129","journal-title":"Genes Dev"},{"issue":"6","key":"7262_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41419-021-03811-8","volume":"12","author":"L Su","year":"2021","unstructured":"Su L, Dong Y, Wang Y, Wang Y, Guan B, Lu Y, Wu J, Wang X, Li D, Meng A, Fan F (2021) Potential role of senescent macrophages in radiation-induced pulmonary fibrosis. Cell Death Dis 12(6):527. https:\/\/doi.org\/10.1038\/s41419-021-03811-8","journal-title":"Cell Death Dis"},{"issue":"1","key":"7262_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc2772","volume":"10","author":"M Collado","year":"2010","unstructured":"Collado M, Serrano M (2010) Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10(1):51\u201357. https:\/\/doi.org\/10.1038\/nrc2772","journal-title":"Nat Rev Cancer"},{"issue":"47","key":"7262_CR15","doi-asserted-by":"publisher","first-page":"12500","DOI":"10.1523\/JNEUROSCI.4511-08.2008","volume":"28","author":"S Karunakaran","year":"2008","unstructured":"Karunakaran S, Saeed U, Mishra M, Valli RK, Joshi SD, Meka DP, Seth P, Ravindranath V (2008) Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. J Neurosci 28(47):12500\u201312509. https:\/\/doi.org\/10.1523\/JNEUROSCI.4511-08.2008","journal-title":"J Neurosci"},{"issue":"1","key":"7262_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41467-019-13911-x","volume":"11","author":"D He","year":"2020","unstructured":"He D, Wu H, Xiang J, Ruan X, Peng P, Ruan Y, Chen YG, Wang Y, Yu Q, Zhang H, Habib SL, De Pinho RA, Liu H, Li B (2020) Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway. Nat Commun 11(1):37. https:\/\/doi.org\/10.1038\/s41467-019-13911-x","journal-title":"Nat Commun"},{"issue":"14","key":"7262_CR17","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1167\/iovs.19-27617","volume":"60","author":"M Xiang","year":"2019","unstructured":"Xiang M, Mo L, Zhan Y, Wen H, Zhou H, Miao W (2019) P38-mediated cellular senescence in conjunctivochalasis fibroblasts. Invest Ophthalmol Vis Sci 60(14):4643\u20134651. https:\/\/doi.org\/10.1167\/iovs.19-27617","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"7262_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.cell.2006.11.050","volume":"128","author":"P Sun","year":"2007","unstructured":"Sun P, Yoshizuka N, New L, Moser BA, Li Y, Liao R, Xie C, Chen J, Deng Q, Yamout M, Dong MQ, Frangou CG, Yates JR 3rd, Wright PE, Han J (2007) PRAK is essential for ras-induced senescence and tumor suppression. Cell 128(2):295\u2013308. https:\/\/doi.org\/10.1016\/j.cell.2006.11.050","journal-title":"Cell"},{"issue":"7","key":"7262_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/jmcb\/mjz075","volume":"11","author":"G Sanz","year":"2019","unstructured":"Sanz G, Singh M, Peuget S, Selivanova G (2019) Inhibition of p53 inhibitors: progress, challenges and perspectives. J Mol Cell Biol 11(7):586\u2013599. https:\/\/doi.org\/10.1093\/jmcb\/mjz075","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"7262_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/cancers13010007","volume":"13","author":"M Lapidot","year":"2020","unstructured":"Lapidot M, Case AE, Larios D, Gandler HI, Meng C, To\u0161i\u0107 I, Weisberg EL, Poitras MJ, Gokhale PC, Paweletz CP, Podar K, Salgia R, Saladi SV, Griffin JD, Frank DA, Bueno R, Sattler M (2020) Inhibitors of the transcription factor STAT3 decrease growth and induce immune response genes in models of malignant pleural mesothelioma (MPM). Cancers (Basel) 13(1):7. https:\/\/doi.org\/10.3390\/cancers13010007","journal-title":"Cancers (Basel)"},{"issue":"10125","key":"7262_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, Bonaventure A, Valkov M, Johnson CJ, Est\u00e8ve J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP (2018) Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet 391(10125):1023\u20131075. https:\/\/doi.org\/10.1016\/s0140-6736(17)33326-3","journal-title":"The Lancet"},{"issue":"7","key":"7262_CR22","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/molbev\/msz086","volume":"36","author":"YT Tamer","year":"2019","unstructured":"Tamer YT, Gaszek IK, Abdizadeh H, Batur TA, Reynolds KA, Atilgan AR, Atilgan C, Toprak E (2019) High-order epistasis in catalytic power of dihydrofolate reductase gives rise to a rugged fitness landscape in the presence of trimethoprim selection. Mol Biol Evol 36(7):1533\u20131550. https:\/\/doi.org\/10.1093\/molbev\/msz086","journal-title":"Mol Biol Evol"},{"issue":"9","key":"7262_CR23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ncb3400","volume":"18","author":"J Frede","year":"2016","unstructured":"Frede J, Greulich P, Nagy T, Simons BD, Jones PH (2016) A single dividing cell population with imbalanced fate drives oesophageal tumour growth. Nat Cell Biol 18(9):967\u2013978. https:\/\/doi.org\/10.1038\/ncb3400","journal-title":"Nat Cell Biol"},{"issue":"12","key":"7262_CR24","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.3390\/molecules25122763","volume":"25","author":"DG Kim","year":"2020","unstructured":"Kim DG, Park CM, Huddar S, Lim S, Kim S, Lee S (2020) Anticancer activity of pyrimethamine via ubiquitin mediated degradation of AIMP2-DX2. Molecules 25(12):2763. https:\/\/doi.org\/10.3390\/molecules25122763","journal-title":"Molecules"},{"issue":"1","key":"7262_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-016-0409-9","volume":"35","author":"C Tommasino","year":"2016","unstructured":"Tommasino C, Gambardella L, Buoncervello M, Griffin RJ, Golding BT, Alberton M, Macchia D, Spada M, Cerbelli B, d\u2019Amati G, Malorni W, Gabriele L, Giammarioli AM (2016) New derivatives of the antimalarial drug Pyrimethamine in the control of melanoma tumor growth: an in vitro and in vivo study. J Exp Clin Cancer Res 35(1):137. https:\/\/doi.org\/10.1186\/s13046-016-0409-9","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"7262_CR26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, Campisi J, Collado M, Evangelou K, Ferbeyre G, Gil J, Hara E, Krizhanovsky V, Jurk D, Maier AB, Narita M, Niedernhofer L, Passos JF, Robbins PD, Schmitt CA, Sedivy J, Vougas K, von Zglinicki T, Zhou D, Serrano M, Demaria M (2019) Cellular senescence: defining a path forward. Cell 179(4):813\u2013827. https:\/\/doi.org\/10.1016\/j.cell.2019.10.005","journal-title":"Cell"},{"issue":"3","key":"7262_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s0092-8674(02)00734-1","volume":"109","author":"CA Schmitt","year":"2002","unstructured":"Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW (2002) A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109(3):335\u2013346. https:\/\/doi.org\/10.1016\/s0092-8674(02)00734-1","journal-title":"Cell"},{"issue":"17","key":"7262_CR28","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1038\/sj.onc.1208615","volume":"24","author":"SL Harris","year":"2005","unstructured":"Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24(17):2899\u20132908. https:\/\/doi.org\/10.1038\/sj.onc.1208615","journal-title":"Oncogene"},{"issue":"7407","key":"7262_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Cancer Genome Atlas Network","year":"2012","unstructured":"Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330\u2013337. https:\/\/doi.org\/10.1038\/nature11252","journal-title":"Nature"},{"issue":"1","key":"7262_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41598-017-00315-4","volume":"7","author":"B Li","year":"2017","unstructured":"Li B, Hou D, Guo H, Zhou H, Zhang S, Xu X, Liu Q, Zhang X, Zou Y, Gong Y, Shao C (2017) Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells. Sci Rep 7(1):208. https:\/\/doi.org\/10.1038\/s41598-017-00315-4","journal-title":"Sci Rep"},{"issue":"22","key":"7262_CR31","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.7150\/jca.45176","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, Wu X, Al Rudaisat M, Song Y, Cheng H (2020) Curcumin induces G2\/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells. J Cancer 11(22):6704\u20136715. https:\/\/doi.org\/10.7150\/jca.45176","journal-title":"J Cancer"},{"issue":"5","key":"7262_CR32","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3892\/ijo.2018.4527","volume":"53","author":"RX Liu","year":"2018","unstructured":"Liu RX, Ma Y, Hu XL, Ren WY, Liao YP, Wang H, Zhu JH, Wu K, He BC, Sun WJ (2018) Anticancer effects of oridonin on colon cancer are mediated via BMP7\/p38 MAPK\/p53 signaling. Int J Oncol 53(5):2091\u20132101. https:\/\/doi.org\/10.3892\/ijo.2018.4527","journal-title":"Int J Oncol"},{"issue":"8","key":"7262_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537\u2013549. https:\/\/doi.org\/10.1038\/nrc2694","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"7262_CR34","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1007\/s11033-021-06570-z","volume":"48","author":"C Shi","year":"2021","unstructured":"Shi C, Zhang H, Yu K, Wang Y, Jiang J, Ju Y, Zhang C, Cheng Z, Kan G (2021) Molecular cloning and sequence analysis of a mitogen-activated protein kinase gene in the Antarctic yeast Rhodotorula mucilaginosa AN5. Mol Biol Rep 48(8):5847\u20135855. https:\/\/doi.org\/10.1007\/s11033-021-06570-z","journal-title":"Mol Biol Rep"},{"issue":"8","key":"7262_CR35","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/emboj.2011.69","volume":"30","author":"A Freund","year":"2011","unstructured":"Freund A, Patil CK, Campisi J (2011) p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J 30(8):1536\u20131548. https:\/\/doi.org\/10.1038\/emboj.2011.69","journal-title":"EMBO J"},{"issue":"2","key":"7262_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11357-020-00183-3","volume":"42","author":"C Anerillas","year":"2020","unstructured":"Anerillas C, Abdelmohsen K, Gorospe M (2020) Regulation of senescence traits by MAPKs. Geroscience 42(2):397\u2013408. https:\/\/doi.org\/10.1007\/s11357-020-00183-3","journal-title":"Geroscience"},{"key":"7262_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/1533033819883633","author":"D Mao","year":"2019","unstructured":"Mao D, Hu C, Zhang J, Feng C, Zhang Z, Wang J, Man Z, Zhu Z, Wang Y, Zhao H, Zhu X, Ouyang J, Dong X, Zhao X (2019) Long noncoding RNA GM16343 promotes IL-36beta to regulate tumor microenvironment by CD8+ T cells. Technol Cancer Res Treat. https:\/\/doi.org\/10.1177\/1533033819883633","journal-title":"Technol Cancer Res Treat"},{"issue":"7","key":"7262_CR38","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41590-021-00949-7","volume":"22","author":"JL Collier","year":"2021","unstructured":"Collier JL, Weiss SA, Pauken KE, Sen DR, Sharpe AH (2021) Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity. Nat Immunol 22(7):809\u2013819. https:\/\/doi.org\/10.1038\/s41590-021-00949-7","journal-title":"Nat Immunol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07262-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07262-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07262-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T22:45:50Z","timestamp":1657233950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07262-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7262"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07262-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"19 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies (IACUC-2021110401) were conducted according to the guidelines of the Committee on the Ethics of Animal Experiments of the Sixth Affiliated Hospital, Sun Yat-sen University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}